Filter
4442
Filtered Results: 4442
Text search:
vaccinaton
Featured
Recommendations
444
New Publications
1089
Language
Document type
No document type
2026
Studies & Reports
747
Guidelines
624
Fact sheets
256
Strategic & Response Plan
243
Manuals
200
Situation Updates
100
Resource Platforms
67
Training Material
58
Videos
55
Infographics
38
Brochures
17
Online Courses
11
Countries / Regions
Global
181
Congo, Democratic Republic of
168
India
137
Kenya
92
Senegal
91
Nigeria
88
Western and Central Europe
74
Latin America and the Carribbean
73
South Africa
73
Sierra Leone
72
Syria
68
Liberia
68
Africa
64
Germany
63
Nepal
62
Ethiopia
57
South Sudan
57
Rwanda
56
Uganda
56
Ukraine
55
Benin
55
Burkina Faso
54
Haiti
54
Brazil
53
Bangladesh
46
Tanzania
42
Malawi
40
Zambia
38
Ghana
36
Guinea
35
Middle East and North Africa
35
Cameroon
34
Central African Republic
34
Yemen
33
Myanmar / Burma
33
Namibia
32
West and Central Africa
31
Philippines
30
Mozambique
30
Madagascar
30
East and Southern Africa
28
Russia
28
Zimbabwe
26
Venezuela
26
Eastern Europe
25
South–East Asia Region
24
Lesotho
22
Mali
21
Colombia
20
Afghanistan
20
Pakistan
20
Peru
19
Cambodia
18
Argentina
16
Indonesia
16
Eastern Europe and Central Asia
15
Togo
14
Niger
14
Asia
14
Sudan
14
Somalia
14
Côte d’Ivoire / Ivory Coast
13
Western Pacific Region
12
Lebanon
12
Chile
10
Jordan
9
Paraguay
9
Botswana
9
Chad
8
Ecuador
8
Burundi
7
Angola
7
Eswatini/ Swaziland
7
Bolivia
6
Iraq
6
Thailand
5
Mexico
5
China
5
United Kingdom
5
Moldova
5
Palestine
5
Libya
5
USA
4
Guinea-Bissau
4
France
4
Vietnam
4
Tajikistan
3
El Salvador
3
Turkey
3
Iran
3
Albania
3
Laos
3
Congo-Brazzaville
3
Morocco
3
Jamaica
3
Mauritius
3
Tunisia
3
Sri Lanka
3
Egypt
3
Poland
3
North Macedonia
2
Timor Leste/ East Timor
2
Serbia
2
Bulgaria
2
Italy
2
Hungary
2
Saudi Arabia
2
Papua New Guinea
2
Georgia
2
Switzerland
1
Gambia
1
Fiji
1
Uzbekistan
1
Malaysia
1
Qatar
1
Mauritania
1
Armenia
1
Lithuania
1
Gabon
1
Maldives
1
Portugal
1
Spain
1
South Korea
1
French Guyana
1
Nicaragua
1
Djibouti
1
Romania
1
Slovakia
1
Greece
1
Honduras
1
Bhutan
1
Solomon Islands
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
1820
Clinical Guidelines
371
Women & Child Health
230
Key Resources
213
Public Health
188
Capacity Building
43
Pharmacy & Technologies
29
Annual Report MEDBOX
2
Toolboxes
COVID-19
843
Rapid Response
250
TB
205
Ebola & Marburg
174
HIV
159
Refugee
152
AMR
137
Conflict
136
NTDs
96
Planetary Health
88
Polio
88
Mental Health
84
Caregiver
77
Malaria
74
Cholera
70
Disability
59
Health Financing Toolbox
51
Global Health Education
49
Natural Hazards
44
Pharmacy
39
NCDs
31
Zika
24
Specific Hazards
7
Typhoon
5
South Sudan
1
Les notes d’orientation décrivent les mesures essentielles que les décideurs aux niveaux national et infranational peuvent mettre en place concernant les aspects suivants : les tests de diagnostic de la COVID19, la prise en charge clinique de la COVID-19, la réalisation des cibles en matière ...
The current outbreak of Ebola in west Africa constitutes the largest and most complex to date. Declared a public health emergency of international concern by WHO, the outbreak of a disease with no known treatment or vaccination is proving difficult to contain given the already fragile and under res...
Sep 22, 2021.
In our updated analysis we find that, as of September 9, there continue to be wide disparities in access and at current rates, most low-income countries (LICs) and most countries in Africa will not reach global vaccination targets. We also find that, compared to July, the rate at whic...
The Zimbabwe Multi-Sectoral Cholera Elimination Plan (2018–2028) aims to eradicate cholera by improving water, sanitation, and healthcare infrastructure, strengthening disease surveillance, and expanding oral cholera vaccination (OCV). The strategy focuses on five pillars, including public health ...
WHO‘s Global Strategy to Accelerate the Elimination of Cervical Cancer, launched today, outlines three key steps: vaccination, screening and treatment. Successful implementation of all three could reduce more than 40% of new cases of the disease and 5 million related deaths by 2050.
Highlights:
- IOM teams reach populations in need in Baggari, south of Wau
- Rapid response teams conduct oral cholera vaccination campaigns across the country
- IOM expands fuel-efficient stove initiative in the Bentiu PoC site
What do we know about the Delta variant so far? How can we assess our risk? What strategies should we apply to protect ourselves whether we are in a low vaccination or high vaccination setting? WHO’s Dr Maria Van Kerkhove explains in Science in 5.
Trop. Med. Infect. Dis. 2018, 3, 72;
The study identified some key determinants of untimely and incomplete childhood vaccinations in the context of Bangladesh. The findings will contribute to the improvement of age-specific vaccination and support policy makers in taking the necessary control ...
The study identified some key determinants of untimely and incomplete childhood vaccinations in the context of Bangladesh. The findings will contribute to the improvement of age-specific vaccination and support policy makers in taking the necessary control ...
The WHO Guide on Oral Cholera Vaccines in Mass Immunization Campaigns provides guidance on the planning and implementation of oral cholera vaccine (OCV) campaigns. It covers key aspects such as when and where to use OCVs, vaccine specifications, and recommendations for use in endemic areas, outbreak...
The technical note by the Global Task Force on Cholera Control (GTFCC) discusses the use of Oral Cholera Vaccines (OCVs) for international workers and travelers in cholera-affected areas. It reviews the effectiveness of WHO-prequalified vaccines (Dukoral®, Shanchol™, and Euvichol®), emphasizing ...
La méningite est mortelle et débilitante ; elle frappe brutalement ; elle a de graves conséquences sanitaires, économiques et sociales et touche tous les âges de la vie dans tous les pays du monde. La méningite bactérienne peut être à l’origine d’épidémies, entraîner la mort dans les...
31 March 2021
This article is part of a series of explainers on vaccine development and distribution. Learn more about vaccines – from how they work and how they’re made to ensuring safety and equitable access – in WHO’s Vaccines Explained series.
Vaccines are a critical tool in the battl...
Breakthrough ACTION a développé des affiches, des spots audiovisuels et des bannières pour le lancement du vaccin antipaludique R21/Matrix M en la République du Congo. Ces messages visent à promouvoir l’acceptation et l’utilisation du vaccin contre le paludisme. Cet effort a impliqué une c...
These organisations have joined forces to accelerate access to COVID-19 vaccines, therapeutics and diagnostics by leveraging multilateral finance and trade solutions, particularly for low- and middle-income countries.
The aim is to vaccinate at least 40 percent of people in every country by the end...
Do the current batch of approved vaccines protect us from the Delta variant? What is the level of protection? If you can still get infected even after being fully vaccinated, then why should we vaccinate? WHO’s Chief Scientist Dr Soumya Swaminathan explains in Science in 5.
The arrival of safe, effective COVID-19 vaccines is a major development in the coronavirus pandemic. An effective COVID-19 vaccine will help protect people who come in contact with the virus from becoming sick. As more people are vaccinated, families and communities will be able to gradually return ...
If you have COVID-19, is it safe to breastfeed your baby? Is it safe to get vaccinated against COVID-19 if you are breastfeeding? How can you keep your baby safe while breastfeeding if you have COVID-19? Dr Laurence Grummer- Strawn explains in Science in 5.
As new variants emerge people are wondering if they should wait until a more efficacious vaccine is available or if they should go ahead and get vaccinated now? Answering your questions on COVID-19 vaccines and variants in this episode of Science in 5 is WHO's Dr Soumya Swaminathan.
When can we expect a vaccine for COVID-19? How will we ensure that it is safe? Who should be vaccinated first and why? Find out the answers to these and other questions.
A regimen of four 1-mL doses of HDCV or PCEC vaccines should be administered intramuscularly to previously unvaccinated persons.
The first dose of the four-dose course should be administered as soon as possible after exposure. Additional doses should be administered on days 3, 7, and 14 after the...
